These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 12081140)

  • 1. Metabolism of ginsenoside R(c) by human intestinal bacteria and its related antiallergic activity.
    Bae EA; Choo MK; Park EK; Park SY; Shin HY; Kim DH
    Biol Pharm Bull; 2002 Jun; 25(6):743-7. PubMed ID: 12081140
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolism of 20(S)- and 20(R)-ginsenoside Rg3 by human intestinal bacteria and its relation to in vitro biological activities.
    Bae EA; Han MJ; Choo MK; Park SY; Kim DH
    Biol Pharm Bull; 2002 Jan; 25(1):58-63. PubMed ID: 11824558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Constitutive beta-glucosidases hydrolyzing ginsenoside Rb1 and Rb2 from human intestinal bacteria.
    Bae EA; Park SY; Kim DH
    Biol Pharm Bull; 2000 Dec; 23(12):1481-5. PubMed ID: 11145182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transformation of ginseng saponins to ginsenoside Rh2 by acids and human intestinal bacteria and biological activities of their transformants.
    Bae EA; Han MJ; Kim EJ; Kim DH
    Arch Pharm Res; 2004 Jan; 27(1):61-7. PubMed ID: 14969341
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolism of ginsenoside Re by human intestinal microflora and its estrogenic effect.
    Bae EA; Shin JE; Kim DH
    Biol Pharm Bull; 2005 Oct; 28(10):1903-8. PubMed ID: 16204943
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolism of ginsenoside Rb1 by human intestinal microflora and cloning of its metabolizing β-D-glucosidase from Bifidobacterium longum H-1.
    Jung IH; Lee JH; Hyun YJ; Kim DH
    Biol Pharm Bull; 2012; 35(4):573-81. PubMed ID: 22466563
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intestinal bacterial hydrolysis is required for the appearance of compound K in rat plasma after oral administration of ginsenoside Rb1 from Panax ginseng.
    Akao T; Kida H; Kanaoka M; Hattori M; Kobashi K
    J Pharm Pharmacol; 1998 Oct; 50(10):1155-60. PubMed ID: 9821663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiallergic activity of hesperidin is activated by intestinal microflora.
    Lee NK; Choi SH; Park SH; Park EK; Kim DH
    Pharmacology; 2004 Aug; 71(4):174-80. PubMed ID: 15240993
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiallergic activity of ginseng and its ginsenosides.
    Choo MK; Park EK; Han MJ; Kim DH
    Planta Med; 2003 Jun; 69(6):518-22. PubMed ID: 12865969
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiallergic activity of ginsenoside Rh2.
    Park EK; Choo MK; Kim EJ; Han MJ; Kim DH
    Biol Pharm Bull; 2003 Nov; 26(11):1581-4. PubMed ID: 14600405
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biotransformation and metabolic profile of American ginseng saponins with human intestinal microflora by liquid chromatography quadrupole time-of-flight mass spectrometry.
    Wan JY; Liu P; Wang HY; Qi LW; Wang CZ; Li P; Yuan CS
    J Chromatogr A; 2013 Apr; 1286():83-92. PubMed ID: 23499252
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of broad-spectrum antibiotics on the metabolism and pharmacokinetics of ginsenoside Rb1: a study on rats׳ gut microflora influenced by lincomycin.
    Xu R; Peng Y; Wang M; Fan L; Li X
    J Ethnopharmacol; 2014 Dec; 158 Pt A():338-44. PubMed ID: 25446586
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Metabolism of six saponins by rat intestinal bacteria in vitro].
    Gao X; Geng T; Ma Y; Li YJ; Huang WZ; Wang ZZ; Xiao W
    Zhongguo Zhong Yao Za Zhi; 2016 Jun; 41(12):2329-2338. PubMed ID: 28901081
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A review of biotransformation and pharmacology of ginsenoside compound K.
    Yang XD; Yang YY; Ouyang DS; Yang GP
    Fitoterapia; 2015 Jan; 100():208-20. PubMed ID: 25449425
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative analysis of the gut microbiota in people with different levels of ginsenoside Rb1 degradation to compound K.
    Kim KA; Jung IH; Park SH; Ahn YT; Huh CS; Kim DH
    PLoS One; 2013; 8(4):e62409. PubMed ID: 23638073
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibiotics attenuate anti-scratching behavioral effect of ginsenoside Re in mice.
    Jang SE; Jung IH; Joh EH; Han MJ; Kim DH
    J Ethnopharmacol; 2012 Jun; 142(1):105-112. PubMed ID: 22855946
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Purification and characterization of ginsenoside Ra-hydrolyzing beta-D-xylosidase from Bifidobacterium breve K-110, a human intestinal anaerobic bacterium.
    Shin HY; Lee JH; Lee JY; Han YO; Han MJ; Kim DH
    Biol Pharm Bull; 2003 Aug; 26(8):1170-3. PubMed ID: 12913270
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bioactivity and bioavailability of ginsenosides are dependent on the glycosidase activities of the A/J mouse intestinal microbiome defined by pyrosequencing.
    Niu T; Smith DL; Yang Z; Gao S; Yin T; Jiang ZH; You M; Gibbs RA; Petrosino JF; Hu M
    Pharm Res; 2013 Mar; 30(3):836-46. PubMed ID: 23254888
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biotransformation of ginsenoside Rb1, crocin, amygdalin, geniposide, puerarin, ginsenoside Re, hesperidin, poncirin, glycyrrhizin, and baicalin by human fecal microflora and its relation to cytotoxicity against tumor cells.
    Kim YS; Kim JJ; Cho KH; Jung WS; Moon SK; Park EK; Kim DH
    J Microbiol Biotechnol; 2008 Jun; 18(6):1109-14. PubMed ID: 18600055
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proof of the mysterious efficacy of ginseng: basic and clinical trials: metabolic activation of ginsenoside: deglycosylation by intestinal bacteria and esterification with fatty acid.
    Hasegawa H
    J Pharmacol Sci; 2004 Jun; 95(2):153-7. PubMed ID: 15215638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.